Pediatric Ischemic Stroke Epidemiology Forecast 2025-2034

Ischemic stroke is typically considered a rarely encountered event in children as compared to the adult population. Studies show that the incidence of combined ischemic and hemorrhagic pediatric stroke is estimated to range from 1.2 to 13 cases per 100,000 children aged under 18 years.

Pediatric Ischemic Stroke Epidemiology Forecast Report Coverage

Expert Market Research's “Pediatric Ischemic Stroke Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of pediatric ischemic stroke. It projects the future incidence and prevalence rates of pediatric ischemic stroke across various populations. The study covers age and type as major determinants of the pediatric ischemic stroke-affected population. The report highlights patterns in the prevalence of pediatric ischemic stroke over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of pediatric ischemic stroke in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Pediatric Ischemic Stroke: Disease Overview

Pediatric ischemic stroke is a rare condition in which obstruction of blood flow occurs to the child's brain, leading to tissue damage along with long-term physical, cognitive, and developmental impairments. Ischemic stroke in the pediatric population is typically classified into two main types: arterial ischemic stroke and cerebral sinovenous thrombosis. Congenital heart defects, severe infections like meningitis or sepsis, and blood disorders (sickle cell anemia and clotting disorders) can increase the likelihood of an ischemic stroke in children.

Pediatric Ischemic Stroke: Treatment Overview

The treatment of pediatric ischemic stroke is primarily focused on restoring blood flow and minimizing brain damage in the affected area. Anticoagulants such as heparin or low-molecular-weight heparin may be used to prevent further clot formation. Thrombolytic therapy (tissue plasminogen activator (tPA)) is considered in certain cases and requires specialized evaluation. Antiplatelet medications like aspirin are commonly prescribed to prevent clot formation, especially in children with arterial ischemic stroke.

Epidemiology

The pediatric ischemic stroke epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for pediatric ischemic strokes by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pediatric ischemic stroke and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Acute ischemic stroke is a rare medical event in children, occurring at an incidence rate of about 1 in 3,500 newborns and 1 to 2 in 100,000 children each year. The risk is highest during the perinatal period (around birth), in children under 5 years old, and during adolescence.
• Asian and black children are more likely to experience an earlier onset of acute ischemic stroke due to a higher prevalence of concurrent chronic conditions. The relative risk in Asian and black children is estimated to be 2.14 and 2.28, respectively, compared to 1.34 for children of other ethnicities.
• Stroke is one of the top 10 causes of death in children. Pediatric stroke affects approximately 1 in 4,000 newborns and about 2,000 older children annually.
• The combined incidence of ischemic and hemorrhagic strokes is reported to range from 1.2 to 13 cases per 100,000 children under 18 years old.

Country-wise Pediatric Ischemic Stroke Epidemiology

The pediatric ischemic stroke epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of pediatric ischemic strokes varies significantly between countries due to differences in the prevalence of underlying conditions (such as congenital heart defects or sickle cell anemia), genetic predispositions, socioeconomic conditions, regional variations in infection rates or environmental triggers, and access to treatment and diagnostic tools, among others. As per a study published in AHA/ASA (American Heart Association/American Stroke Association) Journals (2024), the burden of stroke in children is increasing, particularly among females, children below the age of 5 years, and in low-sociodemographic index countries like sub-Saharan Africa.

Country Specific Stats:

Country

Prevalence (Unit)

United States

United Kingdom

Germany

Italy

France

Spain

Japan

India

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pediatric ischemic stroke based on several factors.
• Pediatric Ischemic Stroke Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of pediatric ischemic strokes are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of pediatric ischemic stroke epidemiology in the 8 major markets?
• What will be the total number of patients with pediatric ischemic strokes across the 8 major markets during the forecast period?
• What was the country-wise prevalence of pediatric ischemic stroke in the 8 major markets in the historical period?
• Which country will have the highest number of pediatric ischemic stroke patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of pediatric ischemic stroke during the forecast period of 2025-2034?
• What are the currently available treatments for pediatric ischemic strokes?
• What are the disease risks, signs, symptoms, and unmet needs of pediatric ischemic stroke?

Related Reports

Ischemic Stroke Market

Haemorrhagic Stroke Treatment Market